Published in Immunology on February 01, 2006
Transspecies transmission of the endogenous koala retrovirus. J Virol (2006) 1.45
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41. PLoS Pathog (2011) 0.98
Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses. Clin Microbiol Rev (2012) 0.97
Koala retroviruses: characterization and impact on the life of koalas. Retrovirology (2013) 0.88
Immunization with hybrid proteins containing the membrane proximal external region of HIV-1. AIDS Res Hum Retroviruses (2014) 0.81
Immunising with the transmembrane envelope proteins of different retroviruses including HIV-1: a comparative study. Hum Vaccin Immunother (2012) 0.80
Increased titers of neutralizing antibodies after immunization with both envelope proteins of the porcine endogenous retroviruses (PERVs). Virol J (2012) 0.80
Sequence variation of koala retrovirus transmembrane protein p15E among koalas from different geographic regions. Virology (2014) 0.79
Induction of neutralizing antibodies specific for the envelope proteins of the koala retrovirus by immunization with recombinant proteins or with DNA. Virol J (2015) 0.77
Detection of antibodies to the feline leukemia Virus (FeLV) transmembrane protein p15E: an alternative approach for serological FeLV detection based on antibodies to p15E. J Clin Microbiol (2014) 0.76
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol (1993) 10.75
A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (2001) 5.38
The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A (1996) 4.48
Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J Virol (1993) 4.22
The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5. J Virol (2004) 2.02
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates. J Virol (2002) 1.79
An endogenous retrovirus derived from human melanoma cells. Cancer Res (2003) 1.76
Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res (2005) 1.65
Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: implications for fusion-inducing conformational changes. J Virol (2004) 1.58
Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation? Virology (2003) 1.17
Progress towards the development of a HIV-1 gp41-directed vaccine. Curr HIV Res (2004) 1.13
Productive infection of human primary cells and cell lines with porcine endogenous retroviruses. Virology (2001) 1.12
The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients. AIDS (1994) 1.08
Immunosuppression by retroviruses: implications for xenotransplantation. Ann N Y Acad Sci (1998) 1.05
Antibodies: can they protect against HIV infection? Curr Drug Targets Infect Disord (2005) 1.03
Porcine endogenous retroviruses: in vitro host range and attempts to establish small animal models. J Gen Virol (2001) 1.03
Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation. Xenotransplantation (2001) 0.98
Neutralising antibodies against the transmembrane protein of feline leukaemia virus (FeLV). Vaccine (2005) 0.92
Virus safety in xenotransplantation: first exploratory in vivo studies in small laboratory animals and non-human primates. Transpl Immunol (2002) 0.91
Feline leukaemia virus and vaccination. J Feline Med Surg (2003) 0.89
Productive infection of a mink cell line with porcine endogenous retroviruses (PERVs) but lack of transmission to minks in vivo. Arch Virol (2002) 0.89
Porcine endogenous retroviruses (PERVs) and xenotransplantation: screening for transmission in several clinical trials and in experimental models using non-human primates. Ann Transplant (2003) 0.88
Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology (2009) 4.11
Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci U S A (2004) 3.43
The evolutionary dynamics of human endogenous retroviral families. Annu Rev Genomics Hum Genet (2006) 1.79
Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res (2005) 1.65
Failure to detect Borna disease virus antigen and RNA in human blood. J Clin Virol (2006) 1.59
Screening pigs for xenotransplantation: prevalence and expression of porcine endogenous retroviruses in Göttingen minipigs. Xenotransplantation (2013) 1.47
Transspecies transmission of the endogenous koala retrovirus. J Virol (2006) 1.45
No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro. PLoS One (2010) 1.25
Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. J Gen Virol (2008) 1.22
Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells. J Clin Virol (2003) 1.20
Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation? Virology (2003) 1.17
Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines. Melanoma Res (2006) 1.12
Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation. Genes Chromosomes Cancer (2010) 1.07
Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs. Xenotransplantation (2008) 1.04
The role of the immune response during SIVagm infection of the African green monkey natural host. Front Biosci (2004) 1.00
Reconstitution of the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional activity by truncation of the cytoplasmic domain. J Virol (2009) 1.00
Porcine endogenous retroviruses PERV-A and PERV-B infect neither mouse cells in vitro nor SCID mice in vivo. Intervirology (2005) 0.98
Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus during passage in human cells. Virology (2003) 0.97
Molecular cloning and functional characterization of the human endogenous retrovirus K113. Virology (2008) 0.94
Single mutations in the transmembrane envelope protein abrogate the immunosuppressive property of HIV-1. Retrovirology (2012) 0.94
Immunological changes in simian immunodeficiency virus (SIV(agm))-infected African green monkeys (AGM): expanded cytotoxic T lymphocyte, natural killer and B cell subsets in the natural host of SIV(agm). J Gen Virol (2002) 0.93
Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element. Retrovirology (2011) 0.92
Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand. Xenotransplantation (2014) 0.92
The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-- executive summary. Xenotransplantation (2009) 0.92
Characterisation of a human cell-adapted porcine endogenous retrovirus PERV-A/C. Ann Transplant (2010) 0.90
No evidence for infection of human embryonic stem cells by feeder cell-derived murine leukemia viruses. Stem Cells (2005) 0.90
The Rec protein of HERV-K(HML-2) upregulates androgen receptor activity by binding to the human small glutamine-rich tetratricopeptide repeat protein (hSGT). Int J Cancer (2012) 0.89
PDZ Domain-mediated interaction of interleukin-16 precursor proteins with myosin phosphatase targeting subunits. J Biol Chem (2003) 0.89
Expression of porcine endogenous retroviruses (PERV) in different organs of a pig. Virology (2012) 0.86
Absence of transmission of potentially xenotic viruses in a prospective pig to primate islet xenotransplantation study. J Med Virol (2008) 0.86
The transmembrane protein of the human endogenous retrovirus--K (HERV-K) modulates cytokine release and gene expression. PLoS One (2013) 0.85
Generation of neutralising antibodies against porcine endogenous retroviruses (PERVs). Virology (2011) 0.85
Distribution and expression of porcine endogenous retroviruses in multi-transgenic pigs generated for xenotransplantation. Xenotransplantation (2009) 0.84
Immunization with the transmembrane protein of a retrovirus, feline leukemia virus: absence of antigenemia following challenge. Antiviral Res (2010) 0.84
Inhibition of porcine endogenous retroviruses by RNA interference: increasing the safety of xenotransplantation. Virology (2004) 0.83
Increased neutralizing antibody response after simultaneous immunization with leucogen and the feline leukemia virus transmembrane protein. Intervirology (2010) 0.83
No in vivo infection of triple immunosuppressed non-human primates after inoculation with high titers of porcine endogenous retroviruses. Xenotransplantation (2009) 0.82
Long-term effects of PERV-specific RNA interference in transgenic pigs. Xenotransplantation (2012) 0.82
Mode of interaction between the HIV-1-neutralizing monoclonal antibody 2F5 and its epitope. AIDS (2009) 0.82
Immunization with hybrid proteins containing the membrane proximal external region of HIV-1. AIDS Res Hum Retroviruses (2014) 0.81
Staufen-1 interacts with the human endogenous retrovirus family HERV-K(HML-2) rec and gag proteins and increases virion production. J Virol (2013) 0.81
Novel neutralising antibodies targeting the N-terminal helical region of the transmembrane envelope protein p15E of the porcine endogenous retrovirus (PERV). Immunol Res (2014) 0.80
Expression of porcine endogenous retroviruses (PERVs) in melanomas of Munich miniature swine (MMS) Troll. Vet Microbiol (2007) 0.80
Neutralization of porcine endogenous retrovirus by antibodies against the membrane-proximal external region of the transmembrane envelope protein. J Gen Virol (2012) 0.80
Immunisation with foamy virus Bet fusion proteins as novel strategy for HIV-1 epitope delivery. Immunol Res (2013) 0.80
Identification of the feline foamy virus Bet domain essential for APOBEC3 counteraction. Retrovirology (2013) 0.80
Joint production of prime/boost pairs of Fowlpox Virus and Modified Vaccinia Ankara recombinants carrying the same transgene. J Virol Methods (2011) 0.79
Differences in release and determination of subtype of porcine endogenous retroviruses produced by stimulated normal pig blood cells. Intervirology (2003) 0.79
Pattern of seroreactivity against feline foamy virus proteins in domestic cats from Germany. Vet Immunol Immunopathol (2011) 0.79
Immunological properties of the transmembrane envelope protein of the feline foamy virus and its use for serological screening. Virology (2011) 0.78
Absence of PERV specific humoral immune response in baboons after transplantation of porcine cells or organs. Transpl Int (2002) 0.77
No evidence for PERV release by islet cells from German landrace pigs. Ann Transplant (2008) 0.77
Development of sensitive methods for detection of porcine endogenous retrovirus-C (PERV-C) in the genome of pigs. J Virol Methods (2011) 0.77
Aspects of risk assessment and risk management of nosocomial transmission of classical and variant Creutzfeldt-Jakob disease with special attention to German regulations. Contrib Microbiol (2004) 0.77
Analysis of pig-to-human porcine endogenous retrovirus transmission in a triple-species kidney xenotransplantation model. Transpl Int (2005) 0.76
A novel small animal model to study the replication of simian foamy virus in vivo. Virology (2013) 0.76
Optimisation of expression and purification of the feline and primate foamy virus transmembrane envelope proteins using a 96 deep well screen. Protein Expr Purif (2011) 0.76
Construction and characterisation of replicating foamy viral vectors expressing HIV-1 epitopes recognised by broadly neutralising antibodies. Antiviral Res (2013) 0.76
No transmission of porcine endogenous retroviruses (PERVs) in a long-term pig to rat xenotransplantation model and no infection of immunosuppressed rats. Ann Transplant (2008) 0.76
Retroviral safety: analyses of phylogeny, prevalence and polymorphisms of porcine endogenous retroviruses. Ann Transplant (2003) 0.75
Expression-analysis of the human endogenous retrovirus HERV-K in human astrocytic tumors. BMC Res Notes (2014) 0.75
Vaccine development using the simian immunodeficiency virus model for AIDS. Intervirology (2002) 0.75
Simian immunodeficiency viruses with defective nef genes show increased susceptibility to the noncytotoxic antiviral activity of CD8+ lymphocytes. Virology (2002) 0.75
Visualization of HIV-1 budding structures. AIDS Res Hum Retroviruses (2014) 0.75
[First clinical study in Germany. Vaccination against HIV coming soon?]. MMW Fortschr Med (2003) 0.75
Regulation of Clinical Xenotransplantation-Time for a Reappraisal. Transplantation (2017) 0.75
Unsung hero Robert C. Gallo. Science (2009) 0.75
[In Asia an influenza "supervirus" could develop. Are we armed for the next influenza pandemic? interview by Waldtraud Paukstadt)]. MMW Fortschr Med (2004) 0.75
Biosecurity: risk and response. Int J Med Microbiol (2004) 0.75
[Infectious diseases: How big is the real danger? Interview by Strehlow Karen]. Dtsch Med Wochenschr (2005) 0.75
Improved pig donor screening including newly identified variants of porcine endogenous retrovirus-C (PERV-C). Arch Virol (2012) 0.75